137 related articles for article (PubMed ID: 12680422)
1. Alefacept: potential new therapy for patients with moderate-to-severe psoriasis.
Shukla VK
Issues Emerg Health Technol; 2003 Apr; (45):1-4. PubMed ID: 12680422
[TBL] [Abstract][Full Text] [Related]
2. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.
Scheinfeld N
J Dermatolog Treat; 2007; 18(4):197-208. PubMed ID: 17671880
[TBL] [Abstract][Full Text] [Related]
3. Clinical update on alefacept: consideration for use in patients with psoriasis.
Gade JN
J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S33-7. PubMed ID: 15253688
[TBL] [Abstract][Full Text] [Related]
4. An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy.
Goffe B; Papp K; Gratton D; Krueger GG; Darif M; Lee S; Bozic C; Sweetser MT; Ticho B
Clin Ther; 2005 Dec; 27(12):1912-21. PubMed ID: 16507377
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.
Menter A; Cather JC; Baker D; Farber HF; Lebwohl M; Darif M
J Am Acad Dermatol; 2006 Jan; 54(1):61-3. PubMed ID: 16384756
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
Ellis CN; Krueger GG;
N Engl J Med; 2001 Jul; 345(4):248-55. PubMed ID: 11474662
[TBL] [Abstract][Full Text] [Related]
7. Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
van de Kerkhof P; Griffiths CE; Christophers E; Lebwohl M; Krueger GG
Dermatology; 2005; 211(3):256-63. PubMed ID: 16205071
[TBL] [Abstract][Full Text] [Related]
8. Efalizumab: new drug. Plaque psoriasis: too many unknowns.
Prescrire Int; 2006 Feb; 15(81):8-11. PubMed ID: 16548097
[TBL] [Abstract][Full Text] [Related]
9. Alefacept: a safety profile.
Scheinfeld N
Expert Opin Drug Saf; 2005 Nov; 4(6):975-85. PubMed ID: 16255657
[TBL] [Abstract][Full Text] [Related]
10. Alefacept is well tolerated in patients with chronic plaque psoriasis.
Gottlieb AB
J Cutan Med Surg; 2004 Dec; 8 Suppl 2():14-9. PubMed ID: 15668751
[TBL] [Abstract][Full Text] [Related]
11. Possibilities of using alefacept in the treatment of psoriasis.
Pietrzak A; Chodorowska G; Bartkowiak-Emeryk M; Pietrzak B; Urban J; Juszkiewicz-Borowiec M; Miturska R
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):311-3. PubMed ID: 15323211
[TBL] [Abstract][Full Text] [Related]
12. Development and use of alefacept to treat psoriasis.
Krueger GG; Callis KP
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S87-97. PubMed ID: 12894131
[TBL] [Abstract][Full Text] [Related]
13. Alefacept treatment for chronic plaque psoriasis.
Dunn LK; Feldman SR
Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
15. Alefacept for the treatment of psoriasis and other dermatologic diseases.
Strober BE; Menon K
Dermatol Ther; 2007; 20(4):270-6. PubMed ID: 17970892
[TBL] [Abstract][Full Text] [Related]
16. Alefacept for psoriasis and psoriatic arthritis.
Gottlieb AB
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv58-60. PubMed ID: 16239390
[TBL] [Abstract][Full Text] [Related]
17. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
Ortonne JP; Prinz JC
Eur J Dermatol; 2004; 14(1):41-5. PubMed ID: 14965795
[TBL] [Abstract][Full Text] [Related]
18. The use of alefacept in the treatment of psoriasis.
Wong VK; Lebwohl M
Skin Therapy Lett; 2003 Sep; 8(6):1-2, 7. PubMed ID: 14610613
[TBL] [Abstract][Full Text] [Related]
19. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
Krueger GG
Expert Opin Biol Ther; 2002 Apr; 2(4):431-41. PubMed ID: 11955280
[TBL] [Abstract][Full Text] [Related]
20. Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.
Gordon KB; Vaishnaw AK; O'Gorman J; Haney J; Menter A;
Arch Dermatol; 2003 Dec; 139(12):1563-70. PubMed ID: 14676071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
